Fortunately, people who have mild to moderate symptoms typically recover in a few days or weeks.Feb 25, 2022
But for an estimated 37% who contract the virus, symptoms can linger for weeks, months, or even years. One of the most common symptoms of long COVID is brain fog: a life-altering condition characterized by slow thinking, confusion, difficulty remembering things, and poor concentration.Feb 10, 2022
Most people with COVID-19 are no longer contagious 5 days after they first have symptoms and have been fever-free for at least three days.Apr 1, 2022
Most patients with more severe-to-critical illness likely remain infectious no longer than 20 days after symptom onset.
For people who have had COVID-19, lingering COVID-19 heart problems can complicate their recovery. Some of the symptoms common in coronavirus “long-haulers,” such as palpitations, dizziness, chest pain and shortness of breath, may be due to heart problems — or, just from having been ill with COVID-19.Dec 8, 2021
A full year has passed since the COVID-19 pandemic began, and the mind-boggling aftermath of the virus continues to confuse doctors and scientists. Particularly concerning for doctors and patients alike are lingering side effects, such as memory loss, reduced attention and an inability to think straight.Apr 26, 2021
Researchers estimate that people who get infected with the coronavirus can spread it to others 2 to 3 days before symptoms start and are most contagious 1 to 2 days before they feel sick.Feb 3, 2022
A person with COVID-19 is considered infectious starting 2 days before they develop symptoms, or 2 days before the date of their positive test if they do not have symptoms.
Available data suggest that patients with mild-to-moderate COVID-19 remain infectious no longer than 10 days after symptom onset.
As CDC noted in its updated guidance, people tend to be most infectious towards the beginning of a Covid-19 infection. So, by the time you reach day eight, nine, or 10, you still have the chance to spread to other people, but it's probably not as much as you did early in the course of your infection.Jan 24, 2022
See full answerPersons who have tested persistently or recurrently positive for SARS-CoV-2 RNA have, in some cases, had their signs and symptoms of COVID-19 improve. When viral isolation in tissue culture has been attempted in such persons in South Korea and the United States, live virus has not been isolated. There is no evidence to date that clinically recovered persons with persistent or recurrent detection of viral RNA have transmitted SARS-CoV-2 to others.Despite these observations, it’s not possible to conclude that all persons with persistent or recurrent detection of SARS-CoV-2 RNA are no longer infectious. There is no firm evidence that the antibodies that develop in response to SARS-CoV-2 infection are protective. If these antibodies are protective, it’s not known what antibody levels are needed to protect against reinfection.
See full answerThe following applies to a person who has clinically recovered from SARS-CoV-2 infection that was confirmed with a viral diagnostic test and then, within 3 months since the date of symptom onset of the previous illness episode (or date of positive viral diagnostic test if the person never experienced symptoms), is identified as a contact of a new case. If the person remains asymptomatic since the new exposure, then they do not need to be retested for SARS-CoV-2 and do not need to be quarantined. However, if the person experiences new symptoms consistent with COVID-19 and an evaluation fails to identify a diagnosis other than SARS-CoV-2 infection (e.g., influenza), then repeat viral diagnostic testing may be warranted, in consultation with an infectious disease specialist and public health authorities for isolation guidance.